Clinical Trial

Effective Dose of Alfentanil Combined With Propofol for Laryngeal Mask Airway Insertion in Children

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study uses a prospective, up-and-down sequential allocation method to determine the median effective dose (ED50) and 95% effective dose (ED95) of alfentanil combined with propofol for successful laryngeal mask airway (LMA) insertion in children aged 7-12 undergoing elective day surgery.
Trial Details
NCT Number NCT07581665
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions Pediatric Anesthesia, Airway Management, General Anesthesia, LMA
Enrollment 40 participants
Start Date 2026-05-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12